Evidence-based management of dermatophytosis in India today
Introduction: Dermatophyte infection has become extremely resistant and widespread in all parts of India during the past decade. A change in the major causative organism has been identified to be a major factor behind the change in the character of the infection. The epidemiological shift has been a...
Saved in:
Main Authors: | Aparajita Ghosh, Saumya Panda |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2023-01-01
|
Series: | Apollo Medicine |
Subjects: | |
Online Access: | http://www.apollomedicine.org/article.asp?issn=0976-0016;year=2023;volume=20;issue=1;spage=32;epage=37;aulast=Ghosh |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Terbinafine Resistant Trichophyton Indotineae in Sweden
by: Sahel Mohseni, et al.
Published: (2025-02-01) -
Emerging antifungal resistance in Trichophyton mentagrophytes: insights from susceptibility profiling and genetic mutation analysis
by: Yakun Shao, et al.
Published: (2025-12-01) -
Antifungal Treatment for Japanese Patients with Chronic Pulmonary Aspergillosis
by: Takahiro Takazono, et al.
Published: (2024-12-01) -
Antifungal Susceptibility of Dermatophyte Isolates from Patients with Chronic and Recurrent Dermatophytosis
by: Nikhitha Amin, et al.
Published: (2025-01-01) -
Terbinafine versus itraconazole: a long-term, randomized, double-blind, clinical trial in chronic pulmonary aspergillosis. A pilote study
by: Gianfranco Schiraldi, et al.
Published: (2016-03-01)